Barclays PLC Inotiv, Inc. Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$4.18 - $8.64 $29,715 - $61,421	7,109 Added 152.03%	11,785 $51,000
Q4 2022 Feb 13, 2023	BUY	$3.77 - $22.1 $14,846 - $87,029	3,938 Added 533.6%	4,676 $23,000
Q3 2022 Nov 03, 2022	SELL	$9.81 - $26.17 $1,334 - $3,559	-136 Reduced 15.56%	738 $12,000
Q2 2022 Aug 12, 2022	SELL	$9.56 - $25.91 $18,708 - $50,705	-1,957 Reduced 69.13%	874 $8,000
Q1 2022 May 16, 2022	BUY	$18.52 - $40.41 $52,430 - $114,400	2,831 New	2,831 $74,000

8.97M

388K

145K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $60.1M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.